Infectious Diseases
During the era of infectious diseases (from 1870 to 1945), the advent of antimicrobials including therapeutics and prophylactics by mankind could attain control on the then severe mortality rates. However, the disease causative agents proved to be more challenging by emerging as resistant to treatment or to prophylaxis or to contain. Till date, there are several emerging infectious diseases for which successful disease management strategies have not been underplayed to prevent new outbreaks, expansion of the disease endemicity and obviously a prevention mechanism.
Pentavalent is presently focusing on developing a vaccine solution for the deadly infectious disease “Influenza” and an innovative technology to diagnose “Tuberculosis”.